Nov 28
Registration statement
S-1/A
Registration statement
CNSP · CNS Pharmaceuticals, Inc. · Documents
Market Cap
$5.29M
Shares
1.46M
Volume · Nov 12
2870
Avg daily vol (3M)
9663
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
Nov 15
Registration statement
S-1/A
Registration statement
Nov 10
Quarterly report
10-Q
FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Net loss $3.42M
Diluted EPS -$0.09
Oct 24
Current report
8-K
Events of Oct 21
Other events
Oct 21
Registration statement
S-1
Registration statement
Aug 26
Current report
8-K
Events of Aug 25
Shareholder vote results
Aug 19
Current report
8-K
Events of Aug 18
Other events
Aug 16
Current report
8-K
Other events
Aug 15
Current report
8-K
Financial results
Aug 12
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Net loss $3.57M
Diluted EPS -$0.09
Aug 4
Current report
8-K
Events of Aug 3
Other events
Jul 28
Current report
8-K
Events of Jul 27
Other events
Jul 7
Proxy statement
DEF 14A
Meeting Jul 27, 2022
Proxy statement
Jun 27
Proxy statement
PRE 14A
Meeting Jul 27, 2022
Proxy statement
May 16
Current report
8-K
Financial results
May 13
Apr 29
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2021
Mar 3
Current report
8-K
Financial results
Mar 3
Feb 18
Current report
8-K
Delisting notice or listing transfer
Jan 20
Registration statement
S-3
Registration statement
Jan 10
Current report
8-K
Regulation FD disclosure
Jan 6
Current report
8-K
Events of Jan 5
Entered into a material agreement, Unregistered sale of equity, Other events
2021
Dec 3
Current report
8-K
Regulation FD disclosure
Nov 12
Aug 13
Current report
8-K
Financial results
Aug 13
Jul 19
Current report
8-K
Regulation FD disclosure
Jul 1
Current report
8-K
Events of Jun 28
Shareholder vote results, Other events
Jun 8
Proxy statement
DEF 14A
Meeting Jun 28, 2021
Proxy statement
May 27
Proxy statement
PRE 14A
Meeting Jun 28, 2021
Proxy statement
May 18
Current report
8-K
Regulation FD disclosure
May 13
Apr 30
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2020
Mar 17
Current report
8-K
Regulation FD disclosure
Feb 25
Current report
8-K
Regulation FD disclosure
Feb 16
Annual report
10-K/A
Ended Dec 31
Annual report for the period ended Dec 31, 2020
Feb 12
Current report
8-K
Entered into a material agreement
Feb 12
Jan 27
Registration statement
S-3
Registration statement
Jan 7
Current report
8-K
Regulation FD disclosure
2020
Dec 28
Current report
8-K
Events of Dec 22
Entered into a material agreement, Other events
Dec 22
Registration statement
S-1/A
Registration statement
Dec 21
Current report
8-K
Other events
Dec 21
Registration statement
S-1
Registration statement
Dec 11
Current report
8-K
Regulation FD disclosure
Nov 12
Current report
8-K
Regulation FD disclosure
Nov 12
Sep 25
Registration statement
S-1
Registration statement
Sep 21
Current report
8-K
Events of Sep 15
Entered into a material agreement, Unregistered sale of equity
Showing 101–150 of 170 documents